Abstract:Hypothesis: Naturally derived or synthetic anticancer peptides (ACPs) have emerged as a new generation of anticancer agents with higher selectivity for cancer cells and less propensity for drug resistance. Despite the structural diversity of ACPs, a-helix is the most common secondary structure among them. Herein we report the development of a new library of short cationic amphiphilic a-helical ACPs with selective cytotoxicity against colorectal and cervical cancer. Experiments: The peptides had a general formula C(XXYY)3 with C representing amino acid cysteine (providing a -SH group for molecular conjugation), X representing hydrophobic amino acids (isoleucine (I) or leucine (L)), and Y representing cationic amino acids (arginine (R) or lysine (K)). Two variants of the peptides were synthesized by adding additional Isoleucine residues to the C-terminal and replacing the Nterminal cysteine with LC-propargylglycine (LC-G) to investigate the effect of N-terminal and Cterminal variation on the anticancer activity. The structure and physicochemical properties of the peptides were determined by RP-HPLC, LC-MS and CD spectroscopy. The cytotoxicity of the peptides in different cell lines was assessed by MTT test, cell proliferation assay and mitochondrial damage assay. The mechanism of cell selectivity of the peptides was investigated by studying their interfacial behaviour at the air/water and lipid/water interface using Langmuir trough. Findings: The peptides consisting of K residues in their hydrophilic domains exhibited more selective anticancer activity whereas the peptides containing R exhibited strong toxicity in normal cells. The anticancer activity of the peptides was a function of their helical content and their hydrophobicity. Therefore, the addition of two I residues at C-terminal enhanced the anticancer activity of the peptides by increasing their hydrophobicity and their helical content. These two variants also exhibited strong anticancer activity against colorectal cancer multicellular tumour spheroids (MCTS). The higher toxicity of the peptides in cancer cells compared to normal cells was the result of higher penetration into the negatively charged cancer cell membranes, leading to higher cellular uptake, and their cytotoxic effect was mainly exerted by damaging the mitochondrial membranes leading to apoptosis. The results from this study provide a

Cyanobacterial peptides as a prototype for the design of cathepsin D inhibitors.

Design, synthesis, and bioactivities of tasiamide B derivatives as cathepsin D inhibitors.

Cathepsin D inhibitors based on tasiamide B derivatives with cell membrane permeability

Antibody–peptide conjugates deliver covalent inhibitors blocking oncogenic cathepsins

Highly Selective Aza-Nitrile Inhibitors for Cathepsin K, Structural Optimization and Molecular Modeling

Design, Synthesis and Biological Evaluation of Novel Tripeptidyl Epoxyketone Derivatives Constructed from Β-Amino Acid As Proteasome Inhibitors.

Synthesis and biological evaluation of selective pepstatin based trifluoromethylated inhibitors of Cathepsin D

Design, Synthesis and Biological Evaluation of Novel Non-peptide Boronic Acid Derivatives As Proteasome Inhibitors

Interactions of a Low Molecular Weight Inhibitor from Streptomyces sp. MBR04 with Human Cathepsin D: Implications in Mechanism of Inactivation

Exploration of Novel Macrocyclic Dipeptide N-benzyl Amides As Proteasome Inhibitors.

Optimization of Peptidomimetics as Selective Inhibitors for the β-Catenin/T-Cell Factor Protein-Protein Interaction.

Antibody–peptide conjugates for targeted inhibition of cysteine proteases

Design and Synthesis of Novel Cathepsin C Inhibitors with Anti-Inflammatory Activity

Structure‐Based Design of Bicyclic Helical Peptides That Target the Oncogene β‐Catenin

Design and Synthesis of Arylaminoethyl Amides As Noncovalent Inhibitors of Cathepsin S. Part 1.

Cathelicidin-trypsin Inhibitor Loop Conjugate Represents a Promising Antibiotic Candidate with Protease Stability

Molecular Design,pharmacology and Toxicology Optimization of Antimicrobial Peptide from Hydrophis Cyanocinctus,hc-Cath

Advances in Cathepsin S Inhibition: Challenges and Breakthroughs in Drug Development

Design of novel analogues of t-DPH1 with reduced cytotoxicity, taking the three conserved characteristics of the Dermaseptin family as the feasible starting point

Design, Synthesis, and Biological Evaluation of New Cathepsin B-Sensitive Camptothecin Nanoparticles Equipped with A Novel Multifuctional Linker

Rationally Designed Short Cationic Α-Helical Peptides with Selective Anticancer Activity.